NCT00042159View on ClinicalTrials.gov

Transcranial Magnetic Stimulation (TMS) Treatment for Patients With Persistent Auditory Hallucinations

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

July 31, 2003

Study Completion Date

June 30, 2004

Conditions
SchizophreniaHallucinations
Interventions
DEVICE

repetitive transcranial magnetic stimulation

1 Hertz stimulation for 16 minutes per day at 90% motor threshold, 5 sessions each to the two primary cortical targets

Trial Locations (1)

06519

Yale-New Haven Psychiatric Hospital, New Haven

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Yale University

OTHER

NCT00042159 - Transcranial Magnetic Stimulation (TMS) Treatment for Patients With Persistent Auditory Hallucinations | Biotech Hunter | Biotech Hunter